Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. Among authors: piccart m. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Adjuvant systemic therapy for breast cancer.
Roy JA, Piccart MJ. Roy JA, et al. Among authors: piccart mj. Curr Opin Oncol. 1995 Nov;7(6):517-22. doi: 10.1097/00001622-199511000-00007. Curr Opin Oncol. 1995. PMID: 8547399 Review.
Adjuvant systemic therapy for breast cancer.
Piccart MJ, Biganzoli L, Roy JA. Piccart MJ, et al. Curr Opin Oncol. 1996 Nov;8(6):478-84. doi: 10.1097/00001622-199611000-00006. Curr Opin Oncol. 1996. PMID: 8971467 Review.
616 results